PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsNewsDoudna and Charpentier win 2017 Japan Prize for CRISPR

BioNews

Doudna and Charpentier win 2017 Japan Prize for CRISPR

Published 6 February 2017 posted in News and appears in BioNews 887

Author

Dr Linda Wijlaars

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.

Professors Jennifer Doudna and Emmanuelle Charpentier have won the 2017 Japan Prize for their work on the genome-editing technology CRISPR/Cas9....

Professors Jennifer Doudna and Emmanuelle Charpentier have won the 2017 Japan Prize for their work on the genome-editing technology CRISPR/Cas9.

Professor Charpentier, director of the Max Planck Institute for Infection Biology in Berlin, Germany, and Professor Doudna, professor of chemistry and molecular and cell biology at the University of California, Berkeley, will be honoured in a ceremony hosted by the Emperor and Empress of Japan on 19 April. A cash award of 50 million Japanese yen (approximately £360,000) will be given to each laureate.

The third 2017 laureate, Dr Adi Shamir, professor of computer science at the Weizmann Institute, Israel, was awarded the Japan Prize for his contribution to information security through pioneering research on cryptography.

Professors Charpentier and Doudna worked together on a 2012 paper describing the CRISPR/Cas9 technology. With CRISPR, it is possible to make very precise cuts in DNA in a relatively simple manner. Importantly, the technique works in all types of cells and organisms. Although still novel, the technique has already revolutionised research, but is also the subject of a patent dispute between UC Berkeley and the Broad Institute. 

The duo have already won several other major awards for their work on CRISPR, including the 2015 Breakthrough Prize in Life Sciences and the 2016 L'Oreal-UNESCO for Women in Science Award. 

Since 1985, the Japan Prizes have been awarded annually to scientists and engineers from two different fields who have made significant contributions to the advancement of science and technology. The Japan Prize Foundation selects two fields each year for which prizes will be awarded. Up to 13,000 scientists in these fields can then be nominated by scientists and researchers invited by the Foundation, and winners are selected by the Foundation.

Previous winners of the Japan Prize include the inventor of the World Wide Web, Sir Tim Berners-Lee, in 2002, and Kary Mullis in 1993, who went on to win the Nobel Prize for his discovery of the polymerase chain reaction.

Related Articles

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
1 June 2018 • 2 minutes read

CRISPR scientists win prestigious $1m Kavli award

by Jen Willows

Three scientists will share the US$1 million 2018 Kavli prize in Nanoscience 'for the invention of CRISPR-Cas9, a precise nanotool for editing DNA, causing a revolution in biology, agriculture, and medicine'...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
14 July 2017 • 2 minutes read

China sides with Berkeley on CRISPR patent

by Rachel Siden

China's State Intellectual Property Office has granted the University of California a patent on CRISPR-Cas9 gene editing technology in the country.

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
News
8 November 2013 • 3 minutes read

Accurate editing of human DNA now possible, say scientists

by Dr Anna Cauldwell

A molecular technique that enables any part of the human genome to be altered with extreme precision has been hailed by scientists as a breakthrough in genetics...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Court rules Israeli parents cannot use dead son's sperm

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

1 August 2022 • 2 minutes read

First UK medical guidelines issued for trans fertility preservation

1 August 2022 • 2 minutes read

Male age has more impact on IVF birth rate than previously thought

8 August 2022 • 2 minutes read

Placenta and organ formation observed in mouse embryo models

8 August 2022 • 2 minutes read

Complex structures of the human heart bioengineered

8 August 2022 • 1 minute read

Brain tumour gene also linked to childhood cancers

8 August 2022 • 2 minutes read

Lower hormone doses may improve IVF egg quality

8 August 2022 • 2 minutes read

Boosting muscle cell production of gene therapy proteins

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856